Psoriatic-Arthritis
- Home
- Psoriatic-Arthritis
Frequently Asked Questions About TaltzĀ® (Ixekizumab)
Understand the administration, side effects and answers to frequently asked questions about TaltzĀ® (Ixekizumab).
Solutions to Problem Itching
Itching can be relieved by the easily available Z and Z OTC medication combination.
The Role & Importance of Nutrition In SLE, RA, AS, PsA and Chronic Inflammation
Nutrition recommendations for managing chronic inflammatory conditions. Answers to FAQ's from Dr Manno of Johns Hopkins.
Manage Your Inflammation By Improving Your Mind Body Health
Stress may play a role in inflammation that causes pain - learn about Tai Chi, Relaxation, and other coping techniques.
Traveling with Inflammatory Arthritis
Traveling with RA, PsA and other inflammatory conditions can be stressful - make sure you are prepared.
Biologics Offer Relief for People with Psoriasis
Newer biologic medications are giving patients more effective methods of reducing symptoms of psoriasis.
Overview of Psoriatic Arthritis
Understand the symptoms and signs of psoriatic arthritis and how the condition is diagnosed
Management & Treatment of Psoriatic Arthritis
An overview of the types of medications used to treat Psoriatic Arthritis: DMARDS to NSAIDS
Orencia Approved for Use in Psoriatic Arthritis
The U.S. Food and Drug Administration (FDA) has approved ORENCIA (abatacept) for the treatment of adults with active PsA
Updated Guidelines for Treating Psoriatic Arthritis Released
ACR recommends TNF biologic and "treat to target" approach for all individuals with Psoriatic Arthritis.
Cosentyx Highly Effective for Treatment of Scalp Psoriasis
Cosentyx Highly Effective for Treatment of Scalp Psoriasis
Individuals with psoriasis more likely to develop bone fractures
New research shows psoriasis increases risk of bone fractures.
FDA Extends Simponi Approval to Psoriatic Arthritis and Ankylosing Spondylitis
FDA Extends Simponi Approval to Psoriatic Arthritis and Ankylosing Spondylitis
Better Outcomes with Intensive Treatment in Psoriatic Arthritis
Better Outcomes with Intensive Treatment in Psoriatic Arthritis
Drug Payment Assistance Programs for Rheumatoid & Psoriatic Arthritis
Drug Payment Assistance Programs for Rheumatoid & Psoriatic Arthritis
National Psoriasis Foundation Dietary Recommendations for Psoriatic Disease
National Psoriasis Foundation has released dietary recommendations for psoriasis and psoriatic arthritis.
Exercise With Inflammatory Arthritis and Chronic Inflammatory Conditions
A leading doctor outlines the role of exercise in managing AS, RA, PsA, SLE and other inflammatory conditions.
FDA Expands Cimzia Label for Use During Pregnancy
Cimzia provides women with autoimmune inflammatory disease the option to control disease during pregnancy
Building Your Medical Team
Inflammatory arthritis and rheumatoid conditions are complicated-building your medical team is critical for optimal Rx!
Psoriasis Patients Taking Remicade Appear to be at Greater Risk of Infection
Doctors from the UK report on the increased risk of infection with Remicade in the British Journal of Dermatology
Oral Methotrexate Effective for Juvenile Arthritis
Oral Methotrexate Effective for Juvenile Arthritis
Psoriasis and Psoriatic Arthritis: What You See and What You Donāt
Discussion of how psoriatic disease affects women physically and emotionally in all aspects of work and life.
TaltzĀ® Approved for the Treatment of Psoriasis
TaltzĀ® Approved for the Treatment of Psoriasis
Managing Inflammatory Arthritis From Checkpoint Inhibitors
Cancer patients treated with checkpoint inhibitors need to bring symptoms of joint pain to their doctors attention.
IL-23 inhibitor Tremfya effective for treatment of psoriatic arthritis
IL-23 inhibitor Tremfya effective for treatment of psoriatic arthritis
Individuals With Psoriasis Have Increased Cancer Risk
Research suggests that individuals with psoriasis are at increased cancer risk and this may be associated with treatment
theRAConnection Survey Results Suggest Patients Donāt Discuss Treat to Target
theRAConnection Survey Results Suggest Majority of Patients Donāt Discuss Treat to Target Goals With Their Physician
A Third of Individuals with Psoriatic Arthritis Have Used Alternative Treatments
What natural or alternatives treatments have others used that have helped?
Chair Selection During the Covid-19 Pandemic
More and more of us are spending increasing hours in front of computers...
Pregnancy - Psoriasis and Psoriatic Arthritis
Useful tips on successful pregnancy by individuals with psoriatic disease
COVID-19 and Corticosteroids:
The adrenal gland, situated just above the kidneys, produces a number of hormones that are essential for normal body...
Rinvoq (upadacitinib) Effective in Phase 3 Psoriatic Arthritis Study
The JAK inhibitor Rinvoq represents a new treatment option for Psoriatic Arthritis
Is Methotrexate Alone the Best Initial Therapy for Psoriatic Arthritis?
New study suggests Enbrel alone more effective than MTX or combination.
Skyrizi Appears Superior to Humira for Treating Plaque Psoriasis
FDA approves third IL-23 inhibitor for treatment of plaque psoriasis.
Simponi Effective Initial Therapy for Psoriatic Arthritis
SimponiĀ®(golimumab)is one of five marketed TNF inhibitors(TNFi) that is FDA approved for use in psoriatic arthritis(PsA)
Cosentyx Improves Mobility and Quality of Life for Individuals with Psoriasis
Doctors evaluated mobility, self-care, and activities of daily living in Cosentyx treated patients.
Is Bimekizumab the Next Advance in the Treatment of Psoriatic Arthritis?
Dual Inhibition of IL-17 appears promising for treatment of PsA according to University of Rochester led clinical trial
Filgotinib Selective JAK 1 Inhibitor Effective For Psoriatic Arthritis
Research suggests filgotinib can benefit psoriatic arthritis patients with difficult to control disease.
Psoriatic Arthritis Update From 2018 American College of Rheumatology Meeting
Researchers provide updates on Cosentyx, Tremfya, Otezla, Filgotinib, and Taltz treatment for Psoriatic Arthritis